Showing results (221-230 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|October 3, 2015
Rare adverse events due to house dust mite sublingual immunotherapy in pediatric practice: two case reportsNilufer Galip, Nerin BahcecilerImmunotherapy|December 15, 2015
Predictors of tumor-infiltrating lymphocyte efficacy in melanomaDragoslav Zikich, Jacob Schachter, Michal J BesserImmunotherapy|October 3, 2017
Abatacept and granulocyte-colony stimulating factor in a patient with rheumatoid arthritis and neutropeniaMarta Priora, Simone Parisi, Marco Scarati, et al.Immunotherapy|July 7, 2016
Blinatumomab-induced donor T-cell activation for post-stem cell transplant-relapsed acute CD19-positive biphenotypic leukemiaMohammed Alcharakh, Seongseok Yun, Yimin Dong, et al.Immunotherapy|July 7, 2016
IFN-λ cancer immunotherapy: new kid on the blockAhmed Lasfar, Helen Gogas, Andrew Zloza, et al.Immunotherapy|July 7, 2016
Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomasNatalie Vandeven, Paul NghiemImmunotherapy|July 7, 2016
Immunotherapeutic implications of IL-6 blockade for cytokine stormToshio Tanaka, Masashi Narazaki, Tadamitsu KishimotoImmunotherapy|September 8, 2017
PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivoHiromasa Kuroda, Seiji Mabuchi, Katsumi Kozasa, et al.Immunotherapy|September 8, 2017
Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier MarietteXavier MarietteImmunotherapy|July 6, 2016
Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivirCécile H Herbreteau, Mélanie Denizot, Suzanne Lowther, et al.Pageof 188